Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for <i>H. pylori</i> eradication in a randomized-controlled trial.

Valizadeh Toosi, Seyed Mohammad; Maleki, Iradj; Hosseini, Vahid; Shokri-Afra, Hajar

Non-inferiority of reverse hybrid regimen versus standard concomitant regimen for H. pylori eradication in a randomized-controlled trial.

Valizadeh Toosi, Seyed Mohammad; Maleki, Iradj; Hosseini, Vahid; Shokri-Afra, Hajar.

Afiliación

Valizadeh Toosi SM; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Maleki I; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Hosseini V; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shokri-Afra H; Gut and Liver Research Center, Non-communicable Diseases Institute, Mazandaran University of Medical Sciences, Sari, Iran.

Caspian J Intern Med ; 14(4): 687-693, 2023.

Article en En | MEDLINE | ID: mdl-38024170

Palabras clave

Helicobacter pylori infection; Concomitant; Eradication regimens; Randomized controlled-trial.; Reverse hybrid

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 Problema de salud: 1_doencas_nao_transmissiveis Idioma: En Revista: Caspian J Intern Med Año: 2023 Tipo del documento: Article País de afiliación: Irán

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google